Navigation Links
Global Med Technologies(R), Inc. Partners With Biomedical Synergies to Offer Advanced Tissue Tracking Solutions for Hospitals and Surgery Centers
Date:11/4/2008

Proven human tissue/implant tracking solution now available internationally

DENVER, Nov. 4 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, and Biomedical Synergies, Inc. ("BSI"), a privately held healthcare consulting and software development company headquartered in Minneapolis, Minnesota, today announced that they have signed an agreement under which Global Med will distribute TRACS4Life(TM) tissue tracking software. BSI specializes in human tissue/implant tracking management software for the medical industry. Terms of the agreement were not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

TRACS4Life is a best-of-breed tissue tracking software application for hospitals and surgery centers. Built on Microsoft(R) products, TRACS4Life meets and exceeds the Joint Commission tissue management requirements by streamlining the investigations of worst case scenarios, adverse reactions and product recalls. TRACS4Life uses manufacturers' barcodes to track and trace human tissue products and to track non-biologic implants from their entrance into a facility through final disposition.

Historically, there has been little standardization and even less coordination of the handling of human tissue products within healthcare facilities. Currently, most facilities utilize a manual tissue-tracking system, which is time consuming at best, inefficient at least, and rife with opportunities for human error. This decentralized tracking method translates into increased times to process a recall and to investigate an adverse event. One hospital recently shared that their time to manually process a recall of only seven tissue products was over two months. This example provides clear insight into how a manual tissue tracking
'/>"/>

SOURCE Global Med Technologies(R), Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
4. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
5. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
7. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
8. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
9. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
10. Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech...SDAQ: ONCY ) announced today that in connection wi...erwriters have exercised in full their over-allotm...ts. Each unit is comprised of one common share and...old at a price of US$3.00 per unit. Each whole com...
(Date:12/2/2009)...ALEM, Israel, December 2 Gamida Ce...the preclinical (animal study) safety and,efficacy...gy from Weill,Cornell Medical College and Gamida C...ited anemias such as Cooley,s Anemia. , G...to expand, ex vivo,populations of stem/progenitor...
(Date:12/2/2009).... 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc....bal biopharmaceutical company focused on endocrine...S. Food and Drug Administration (FDA) has granted ...pathway inhibitor compound, perifosine (KRX-0401),... myeloma. Keryx Biopharmaceuticals, Inc. ("Keryx")...
(Date:12/1/2009).... Kerry Solomon announced that he has joined Carol...gned website at www.DrKerrySolomon.com , which wa...mon is a proven LASIK, lens implant, and cataract ...zed for his substantial contributions to improving...sted LASIK Surgeons, which screens LASIK surgeons ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
... VALLEY COTTAGE, N.Y., Feb. 5 XTL,Biopharmaceutic...ed notification,that on February 3, 2009 the Compa...ore than 5% of the Company,s outstanding ordinary ...y shareholders, meeting (EGM) of the Company as,so...g matters: , 1. that Boaz Shweiger be and is h...
... TOKYO, February 5 HOYA Corporation today,announc...ecember 31, 2008.,Net sales were 112.7 billion yen... from 147.0 billion yen in the third quarter of 20...he product price resulting from global,economic do...ctro-Optics and,Vision Care, as well as PENTAX tha...
... CHAPEL HILL, N.C., Feb. 5 In today,s tough econo...y, even while focusing on,strategy and tactics to ...etter understand the resources dedicated by biopha...ons, a recent benchmark study was conducted by Bes...ewly published report,"Benchmarks for Optimizing M...
Other Biology Technology:XTL Biopharmaceuticals to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter 2Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008 2New Study Provides Benchmarks for Optimizing Marketing Staff Levels to Drive Growth 2
(Date:12/2/2009)..., PHILADELPHIA Less acculturated Latino men ha...se who are more acculturated to U.S. culture, but ...tting smoking. Details of these findings are publi...ion , a journal of the American Association for Ca...cus on tobacco. , "Acculturation affects smoking...
(Date:12/2/2009)..., , PHILADELPHIA People who smoke their first ci...igher levels of cotinine, a by-product of nicotine...o smoke, regardless of the number of cigarettes sm...ect the risk of lung cancer, our results suggest t... be especially at risk for lung cancer," said rese...
(Date:12/2/2009)... PHILADELPHIA Assurance of a cancer-free status d...computerized tomography (CT) lung-cancer screening...chers wrote in a study published in Cancer Epidem... American Association for Cancer Research. The Dec..., These findings should negate widespread concern...
Breaking Biology News(10 mins):Acculturation affects smoking cessation success among Latinos 2Increased nicotine levels detected in those who light-up earlier 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Second hand smoking results in liver disease study finds 9877 1Second hand smoking results in liver disease study finds 9877 2Ritter Pharmaceuticals Hires Dr Howard Foyt as Executive Vice President Development 26 Chief Medical Officer 56849 1Ritter Pharmaceuticals Hires Dr Howard Foyt as Executive Vice President Development 26 Chief Medical Officer 56849 2ADA FDI World Dental Federation Observe World Oral Health Day 56846 1ADA FDI World Dental Federation Observe World Oral Health Day 56846 2
...07 In a paper published today in the journal Scie... and academic colleagues from the National Univers...n Sweden report the discovery of two common single...uman genome that appear to account for virtually a...are located in the LOXL1 gene on chromosome 15, an...
...cer therapy by blocking the molecular motors invol...ision is being pursued by young Dutch researcher D...inning projects sponsored by the European Science ...h Councils (EuroHORCS). Dekker and her team are t...h the molecular motors that copy DNA during cell d...
..., researchers report for the first time that genet...ures harboring DNA that are inherited only from th...or type 2 diabetes. The study, which highlights t...athogenesis of common diseases, is published onlin...rding to the Centers for Disease Control, 7% of th...
Other Biology News:deCODE discovers cause of major subtype of glaucoma 2ESF EURYI award winner aims to stop cancer cells reading their own DNA 2Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes 2
...internal standard for the quantification of 5-OxoE...-OxoETE is a polyunsaturated keto acid formed by t...imulates cytosolic calcium levels in neutrophils w...es the migration and degranulation of eosinophils ...
...0 kb Autographa californica (AcNPV) polyhedrin loc...NPV polyhedrin promoter and two AcNPV p10 promoter... cloning site, followed by polyhedrin locus-derive...rted polyhedrin promoter has been inserted contain...
...Delivers 4,600 to Over 3 Million Genotypes Per Day...ble of performing 4,600 to over 3 Million genotype...s*, this automated, scalable, multiplexed system c...d 384-well plate, for cost-effective high throughp...
Mouse Anti-HD Monoclonal Antibody, Unconjugated, Clone 3D6 from Abnova Corporation
Biology Products: